US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aridis Pharmaceuticals Inc.

0.0002

0.0000

Volume:6.58K

Turnover:29.73

Market Cap:8.91K

PE:-0.01

High:0.0500

Open:0.0500

Low:0.0002

Close:0.0002

52wk High:0.0500

52wk Low:0.0000

Shares:44.57M

Float Shares:37.96M

Volume Ratio:1.33

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0399

EPS(LYR):-1.6174

ROE:415.66%

ROA:-4.40%

PB:-0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

China CDC Issues Health Protection Guidelines for February 2026 Spring Festival Holiday

Healios Launches Japan Arm of Global Phase 3 Trial for ARDS Stem Cell Therapy

Healios Files Japan Trial Plan for Global Phase 3 ARDS Stem Cell Study

InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway

Benzinga_recent_news

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy

Healios Prioritizes ARDS Clinical Trials Over Stroke Lead Drug HLCM051

MT Newswires Live

MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND

Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody

Press Release: MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development

MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND

The Concentration of Ten-Fold Bull Stocks in This Bull Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARDS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARDS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARDS\",,,,,undefined,":{"symbol":"ARDS","market":"US","secType":"STK","nameCN":"Aridis Pharmaceuticals Inc.","latestPrice":0.0002,"timestamp":1770757200000,"preClose":0.0002,"halted":0,"volume":6579,"delay":15,"changeRate":0,"floatShares":37958700,"shares":44574000,"eps":-0.039914,"marketStatus":"Post-Mkt","change":0,"latestTime":"02-10 16:00:00 EST Delay","open":0.05,"high":0.05,"low":0.0002,"amount":29.7327,"amplitude":249,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.039914,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770771600000},"marketStatusCode":4,"adr":0,"exchange":"EXPERT","adjPreClose":0.0002,"volumeRatio":1.331674},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARDS\",,,,,undefined,":{"symbol":"ARDS","floatShares":37958700,"roa":"-4.40%","roe":"415.66%","lyrEps":-1.617428,"volumeRatio":1.331674,"shares":44574000,"dividePrice":0,"high":0.05,"amplitude":249,"preClose":0.0002,"low":0.0002,"week52Low":0.000001,"pbRate":"-0.00","psRate":"0.00","week52High":0.05,"institutionHeld":0,"latestPrice":0.0002,"eps":-0.039914,"divideRate":0,"volume":6579,"delay":15,"ttmEps":-0.039914,"open":0.05,"prevYearClose":0.0015,"prevWeekClose":0.0002,"prevMonthClose":0.0002,"prevQuarterClose":0.0015,"fiveDayClose":0.0028,"twentyDayClose":0.0003,"sixtyDayClose":0.0002},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARDS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-11-03","symbol":"ARDS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1698984000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-07-19","symbol":"ARDS","reason":null,"defaultRemindTime":1689773400000,"announcedDate":"2023-07-18","type":"delisting","dateTimestamp":1689739200000},{"market":"US","date":"2023-06-08","symbol":"ARDS","fiscalQuarterEnding":"2023/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1686196800000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2023-05-22","symbol":"ARDS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1684728000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-21","symbol":"ARDS","fiscalQuarterEnding":"2022/09","expectedEps":-0.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1669006800000,"reportTimeType":"post","actualEps":-0.42}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARDS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARDS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARDS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARDS","date":"2023-07-17","current":-0.392816,"percent":0.924757,"low":-5.587062,"twenty":-3.267676,"median":-2.120819,"eighty":-0.574899,"high":-0.179871,"avg":-2.082391,"sd":1.334232,"marketCap":11557032},"quantilePoints":[{"date":"2021-02-12","current":-3.670506,"twenty":-3.675065,"median":-2.839191,"eighty":-1.954177,"marketCap":81331074},{"date":"2021-02-19","current":-2.943673,"twenty":-3.67414,"median":-2.850087,"eighty":-1.960835,"marketCap":65225910},{"date":"2021-02-26","current":-2.866447,"twenty":-3.668824,"median":-2.866447,"eighty":-1.974247,"marketCap":63514737},{"date":"2021-03-05","current":-2.516659,"twenty":-3.667657,"median":-2.858714,"eighty":-1.980833,"marketCap":55764127},{"date":"2021-03-12","current":-3.506969,"twenty":-3.663411,"median":-2.866447,"eighty":-1.983039,"marketCap":77707412},{"date":"2021-03-19","current":-3.198065,"twenty":-3.65847,"median":-2.87545,"eighty":-1.989013,"marketCap":70862718},{"date":"2021-03-26","current":-2.952759,"twenty":-3.65705,"median":-2.880075,"eighty":-1.992834,"marketCap":65427225},{"date":"2021-04-01","current":-2.996391,"twenty":-3.656297,"median":-2.886437,"eighty":-1.993261,"marketCap":66918409},{"date":"2021-04-09","current":-2.815401,"twenty":-3.65308,"median":-2.883256,"eighty":-1.994031,"marketCap":62876357},{"date":"2021-04-16","current":-2.836774,"twenty":-3.649715,"median":-2.878988,"eighty":-1.997578,"marketCap":63353674},{"date":"2021-04-23","current":-2.944913,"twenty":-3.641999,"median":-2.883256,"eighty":-2.002364,"marketCap":65768752},{"date":"2021-04-30","current":-3.133529,"twenty":-3.62322,"median":-2.890814,"eighty":-2.004159,"marketCap":69981097},{"date":"2021-05-07","current":-2.816655,"twenty":-3.611554,"median":-2.892879,"eighty":-2.007015,"marketCap":62904357},{"date":"2021-05-14","current":-3.161731,"twenty":-3.611228,"median":-2.893886,"eighty":-2.012033,"marketCap":71834529},{"date":"2021-05-21","current":-2.931832,"twenty":-3.606715,"median":-2.899664,"eighty":-2.014329,"marketCap":66611221},{"date":"2021-05-28","current":-2.857671,"twenty":-3.600447,"median":-2.893886,"eighty":-2.017321,"marketCap":64926283},{"date":"2021-06-04","current":-2.981273,"twenty":-3.598105,"median":-2.893886,"eighty":-2.019714,"marketCap":67734513},{"date":"2021-06-11","current":-3.426239,"twenty":-3.588377,"median":-2.905456,"eighty":-2.022351,"marketCap":77844142},{"date":"2021-06-18","current":-3.282861,"twenty":-3.586939,"median":-2.907332,"eighty":-2.023325,"marketCap":74586595},{"date":"2021-06-25","current":-3.584449,"twenty":-3.586861,"median":-2.916417,"eighty":-2.023381,"marketCap":81438677},{"date":"2021-07-02","current":-3.702711,"twenty":-3.598105,"median":-2.923681,"eighty":-2.023902,"marketCap":84125591},{"date":"2021-07-09","current":-3.5622,"twenty":-3.600447,"median":-2.931832,"eighty":-2.025098,"marketCap":80933195},{"date":"2021-07-16","current":-2.892279,"twenty":-3.600447,"median":-2.929571,"eighty":-2.029338,"marketCap":65712587},{"date":"2021-07-23","current":-2.556083,"twenty":-3.588737,"median":-2.92228,"eighty":-2.031081,"marketCap":58074201},{"date":"2021-07-30","current":-2.46709,"twenty":-3.586939,"median":-2.914146,"eighty":-2.032344,"marketCap":56052275},{"date":"2021-08-06","current":-2.598017,"twenty":-3.586939,"median":-2.907332,"eighty":-2.054144,"marketCap":59026951},{"date":"2021-08-13","current":-2.255441,"twenty":-3.586548,"median":-2.899664,"eighty":-2.062408,"marketCap":54108038},{"date":"2021-08-20","current":-2.103126,"twenty":-3.584449,"median":-2.893886,"eighty":-2.062408,"marketCap":50453989},{"date":"2021-08-27","current":-2.208575,"twenty":-3.569617,"median":-2.892968,"eighty":-2.065174,"marketCap":52983715},{"date":"2021-09-03","current":-2.43119,"twenty":-3.569617,"median":-2.892101,"eighty":-2.066976,"marketCap":58324249},{"date":"2021-09-10","current":-2.314024,"twenty":-3.565712,"median":-2.890814,"eighty":-2.068132,"marketCap":55513442},{"date":"2021-09-17","current":-2.355032,"twenty":-3.563302,"median":-2.882246,"eighty":-2.073231,"marketCap":56497224},{"date":"2021-09-24","current":-2.232008,"twenty":-3.562349,"median":-2.875731,"eighty":-2.074819,"marketCap":53545877},{"date":"2021-10-01","current":-2.108984,"twenty":-3.561625,"median":-2.869864,"eighty":-2.078737,"marketCap":50594529},{"date":"2021-10-08","current":-1.991818,"twenty":-3.56,"median":-2.866447,"eighty":-2.066616,"marketCap":47783722},{"date":"2021-10-15","current":-2.062118,"twenty":-3.55628,"median":-2.852727,"eighty":-2.064621,"marketCap":49470206},{"date":"2021-10-22","current":-1.927377,"twenty":-3.552936,"median":-2.851863,"eighty":-2.060946,"marketCap":46237778},{"date":"2021-10-29","current":-2.050401,"twenty":-3.54501,"median":-2.848637,"eighty":-2.049229,"marketCap":49189126},{"date":"2021-11-05","current":-1.892227,"twenty":-3.540045,"median":-2.839191,"eighty":-2.037417,"marketCap":45394536},{"date":"2021-11-12","current":-1.039553,"twenty":-3.535858,"median":-2.83344,"eighty":-2.024799,"marketCap":40756704},{"date":"2021-11-19","current":-0.842396,"twenty":-3.535008,"median":-2.816655,"eighty":-2.021908,"marketCap":33026984},{"date":"2021-11-26","current":-0.856735,"twenty":-3.529087,"median":-2.806362,"eighty":-2.017919,"marketCap":33589146},{"date":"2021-12-03","current":-0.742026,"twenty":-3.524237,"median":-2.800578,"eighty":-2.010537,"marketCap":29091854},{"date":"2021-12-10","current":-0.820888,"twenty":-3.515406,"median":-2.793326,"eighty":-2.002588,"marketCap":32183742},{"date":"2021-12-17","current":-0.774288,"twenty":-3.509232,"median":-2.78446,"eighty":-1.992834,"marketCap":30356717},{"date":"2021-12-23","current":-0.946351,"twenty":-3.508124,"median":-2.773287,"eighty":-1.987272,"marketCap":37102655},{"date":"2021-12-31","current":-0.835227,"twenty":-3.507078,"median":-2.763568,"eighty":-1.971255,"marketCap":32745903},{"date":"2022-01-07","current":-0.616562,"twenty":-3.506856,"median":-2.759694,"eighty":-1.957517,"marketCap":24172941},{"date":"2022-01-14","current":-0.552038,"twenty":-3.501539,"median":-2.748337,"eighty":-1.935537,"marketCap":21643215},{"date":"2022-01-21","current":-0.573546,"twenty":-3.493391,"median":-2.733735,"eighty":-1.92659,"marketCap":22486457},{"date":"2022-01-28","current":-0.702594,"twenty":-3.491382,"median":-2.729679,"eighty":-1.918927,"marketCap":27545910},{"date":"2022-02-04","current":-0.85315,"twenty":-3.4899,"median":-2.718838,"eighty":-1.906174,"marketCap":33448605},{"date":"2022-02-11","current":-0.921259,"twenty":-3.487888,"median":-2.698489,"eighty":-1.890838,"marketCap":36118872},{"date":"2022-02-18","current":-0.777872,"twenty":-3.484012,"median":-2.681593,"eighty":-1.857586,"marketCap":30497258},{"date":"2022-02-25","current":-0.777872,"twenty":-3.483074,"median":-2.676975,"eighty":-1.851959,"marketCap":30497258},{"date":"2022-03-04","current":-0.63807,"twenty":-3.483074,"median":-2.665021,"eighty":-1.839639,"marketCap":25016184},{"date":"2022-03-11","current":-0.562792,"twenty":-3.479524,"median":-2.653689,"eighty":-1.833656,"marketCap":22064836},{"date":"2022-03-18","current":-0.587885,"twenty":-3.47762,"median":-2.644349,"eighty":-1.818918,"marketCap":23048619},{"date":"2022-03-25","current":-0.59147,"twenty":-3.477366,"median":-2.638047,"eighty":-1.809869,"marketCap":23189159},{"date":"2022-04-01","current":-0.566252,"twenty":-3.475679,"median":-2.616575,"eighty":-1.779813,"marketCap":23891861},{"date":"2022-04-08","current":-0.496303,"twenty":-3.465791,"median":-2.607105,"eighty":-1.773792,"marketCap":20940513},{"date":"2022-04-14","current":-0.604136,"twenty":-3.465415,"median":-2.602542,"eighty":-1.743755,"marketCap":25490292},{"date":"2022-04-22","current":-0.553791,"twenty":-3.462481,"median":-2.598017,"eighty":-1.725372,"marketCap":23366101},{"date":"2022-04-29","current":-0.524423,"twenty":-3.461698,"median":-2.585527,"eighty":-1.712043,"marketCap":22126990},{"date":"2022-05-06","current":-0.478274,"twenty":-3.457058,"median":-2.581707,"eighty":-1.700291,"marketCap":20179814},{"date":"2022-05-13","current":-0.39143,"twenty":-3.445523,"median":-2.570494,"eighty":-1.665546,"marketCap":16515585},{"date":"2022-05-20","current":-0.439786,"twenty":-3.440566,"median":-2.56819,"eighty":-1.645205,"marketCap":18940703},{"date":"2022-05-27","current":-0.452116,"twenty":-3.436897,"median":-2.558469,"eighty":-1.618092,"marketCap":19471751},{"date":"2022-06-03","current":-0.431566,"twenty":-3.433794,"median":-2.556083,"eighty":-1.598302,"marketCap":18586671},{"date":"2022-06-10","current":-0.600082,"twenty":-3.428639,"median":-2.553859,"eighty":-1.580133,"marketCap":25844324},{"date":"2022-06-17","current":-0.579531,"twenty":-3.421994,"median":-2.546545,"eighty":-1.56824,"marketCap":24959244},{"date":"2022-06-24","current":-0.513769,"twenty":-3.41313,"median":-2.540065,"eighty":-1.555467,"marketCap":22126990},{"date":"2022-07-01","current":-0.452116,"twenty":-3.400851,"median":-2.529007,"eighty":-1.539912,"marketCap":19471751},{"date":"2022-07-08","current":-0.505548,"twenty":-3.395701,"median":-2.523421,"eighty":-1.515025,"marketCap":21772958},{"date":"2022-07-15","current":-0.452116,"twenty":-3.393016,"median":-2.517718,"eighty":-1.495641,"marketCap":19471751},{"date":"2022-07-22","current":-0.460296,"twenty":-3.387105,"median":-2.515327,"eighty":-1.463335,"marketCap":19824012},{"date":"2022-07-29","current":-1.015207,"twenty":-3.385697,"median":-2.511586,"eighty":-1.408894,"marketCap":43722932},{"date":"2022-08-05","current":-0.920673,"twenty":-3.381415,"median":-2.506594,"eighty":-1.361051,"marketCap":39651566},{"date":"2022-08-12","current":-0.949445,"twenty":-3.379996,"median":-2.50282,"eighty":-1.359789,"marketCap":40890677},{"date":"2022-08-19","current":-0.68775,"twenty":-3.379213,"median":-2.487287,"eighty":-1.315925,"marketCap":31331817},{"date":"2022-08-26","current":-0.629466,"twenty":-3.377392,"median":-2.472034,"eighty":-1.259928,"marketCap":28676579},{"date":"2022-09-02","current":-0.586724,"twenty":-3.375179,"median":-2.468042,"eighty":-1.086252,"marketCap":26729403},{"date":"2022-09-09","current":-0.742148,"twenty":-3.374217,"median":-2.466333,"eighty":-1.015207,"marketCap":33810040},{"date":"2022-09-16","current":-0.664436,"twenty":-3.371854,"median":-2.461825,"eighty":-0.989367,"marketCap":30269722},{"date":"2022-09-23","current":-0.470157,"twenty":-3.365906,"median":-2.450968,"eighty":-0.946351,"marketCap":21418926},{"date":"2022-09-30","current":-0.36136,"twenty":-3.360417,"median":-2.439002,"eighty":-0.920673,"marketCap":16462480},{"date":"2022-10-07","current":-0.42807,"twenty":-3.357022,"median":-2.432056,"eighty":-0.90692,"marketCap":19501592},{"date":"2022-10-14","current":-0.41968,"twenty":-3.356667,"median":-2.428332,"eighty":-0.900123,"marketCap":19119360},{"date":"2022-10-21","current":-0.42807,"twenty":-3.355429,"median":-2.418104,"eighty":-0.878243,"marketCap":19501592},{"date":"2022-10-28","current":-0.418653,"twenty":-3.355255,"median":-2.405141,"eighty":-0.856735,"marketCap":19072556},{"date":"2022-11-04","current":-0.385263,"twenty":-3.352504,"median":-2.397513,"eighty":-0.835227,"marketCap":17551432},{"date":"2022-11-11","current":-0.355298,"twenty":-3.351704,"median":-2.387363,"eighty":-0.828058,"marketCap":16186321},{"date":"2022-11-18","current":-0.358423,"twenty":-3.351704,"median":-2.382754,"eighty":-0.817304,"marketCap":16328682},{"date":"2022-11-25","current":-0.570968,"twenty":-3.34872,"median":-2.372465,"eighty":-0.802965,"marketCap":18724320},{"date":"2022-12-02","current":-0.602688,"twenty":-3.345928,"median":-2.355032,"eighty":-0.788328,"marketCap":19764560},{"date":"2022-12-09","current":-0.729171,"twenty":-3.344766,"median":-2.343316,"eighty":-0.777872,"marketCap":23912448},{"date":"2022-12-16","current":-0.744363,"twenty":-3.344324,"median":-2.337457,"eighty":-0.777155,"marketCap":24410624},{"date":"2022-12-23","current":-0.78234,"twenty":-3.338852,"median":-2.321106,"eighty":-0.77286,"marketCap":25656064},{"date":"2022-12-30","current":-0.896273,"twenty":-3.337502,"median":-2.310151,"eighty":-0.767149,"marketCap":29392384},{"date":"2023-01-06","current":-1.040588,"twenty":-3.337502,"median":-2.304356,"eighty":-0.767149,"marketCap":34125056},{"date":"2023-01-13","current":-0.968431,"twenty":-3.337277,"median":-2.288331,"eighty":-0.770005,"marketCap":31758720},{"date":"2023-01-20","current":-0.896273,"twenty":-3.335635,"median":-2.284884,"eighty":-0.774288,"marketCap":29392384},{"date":"2023-01-27","current":-0.539207,"twenty":-3.330292,"median":-2.284733,"eighty":-0.767149,"marketCap":17682757},{"date":"2023-02-03","current":-0.522953,"twenty":-3.328325,"median":-2.278871,"eighty":-0.761383,"marketCap":17149708},{"date":"2023-02-10","current":-0.454897,"twenty":-3.321763,"median":-2.270384,"eighty":-0.75278,"marketCap":14917880},{"date":"2023-02-17","current":-0.455732,"twenty":-3.317149,"median":-2.266166,"eighty":-0.74688,"marketCap":14945280},{"date":"2023-02-24","current":-0.444491,"twenty":-3.309098,"median":-2.26141,"eighty":-0.742148,"marketCap":14576629},{"date":"2023-03-03","current":-0.397854,"twenty":-3.304161,"median":-2.253938,"eighty":-0.724102,"marketCap":13047229},{"date":"2023-03-10","current":-0.348863,"twenty":-3.302547,"median":-2.243725,"eighty":-0.716933,"marketCap":11440611},{"date":"2023-03-17","current":-0.409687,"twenty":-3.300826,"median":-2.228382,"eighty":-0.703292,"marketCap":13435272},{"date":"2023-03-24","current":-0.44005,"twenty":-3.30041,"median":-2.21654,"eighty":-0.695425,"marketCap":14431012},{"date":"2023-03-31","current":-0.34555,"twenty":-3.30041,"median":-2.214357,"eighty":-0.676093,"marketCap":11331952},{"date":"2023-04-06","current":-0.291753,"twenty":-3.29957,"median":-2.210892,"eighty":-0.664181,"marketCap":9567761},{"date":"2023-04-14","current":-0.253029,"twenty":-3.297412,"median":-2.208575,"eighty":-0.648107,"marketCap":8297832},{"date":"2023-04-21","current":-0.26293,"twenty":-3.296925,"median":-2.202343,"eighty":-0.63807,"marketCap":8622530},{"date":"2023-04-28","current":-0.208034,"twenty":-3.294155,"median":-2.191,"eighty":-0.630901,"marketCap":6822261},{"date":"2023-05-05","current":-0.198023,"twenty":-3.293462,"median":-2.183656,"eighty":-0.623732,"marketCap":6493955},{"date":"2023-05-12","current":-0.242028,"twenty":-3.292592,"median":-2.171452,"eighty":-0.616325,"marketCap":7937057},{"date":"2023-05-19","current":-0.224426,"twenty":-3.289772,"median":-2.160655,"eighty":-0.605474,"marketCap":7359816},{"date":"2023-05-26","current":-0.215128,"twenty":-3.284113,"median":-2.15585,"eighty":-0.602553,"marketCap":6533641},{"date":"2023-06-02","current":-0.338312,"twenty":-3.282139,"median":-2.149992,"eighty":-0.600025,"marketCap":10274881},{"date":"2023-06-09","current":-0.34335,"twenty":-3.279407,"median":-2.139426,"eighty":-0.591517,"marketCap":10101708},{"date":"2023-06-16","current":-0.330965,"twenty":-3.274532,"median":-2.132784,"eighty":-0.585754,"marketCap":9737325},{"date":"2023-06-23","current":-0.31576,"twenty":-3.271532,"median":-2.132417,"eighty":-0.583612,"marketCap":9289964},{"date":"2023-06-30","current":-0.268159,"twenty":-3.270406,"median":-2.131556,"eighty":-0.579531,"marketCap":7889513},{"date":"2023-07-07","current":-0.287006,"twenty":-3.270406,"median":-2.123811,"eighty":-0.577312,"marketCap":8443990},{"date":"2023-07-14","current":-0.432356,"twenty":-3.267931,"median":-2.121678,"eighty":-0.575421,"marketCap":12720346},{"date":"2023-07-17","current":-0.392816,"twenty":-3.267676,"median":-2.120819,"eighty":-0.574899,"marketCap":11557032}],"updateTime":1770764054557},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARDS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1142300209","title":"China CDC Issues Health Protection Guidelines for February 2026 Spring Festival Holiday","url":"https://stock-news.laohu8.com/highlight/detail?id=1142300209","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142300209?lang=en_us&edition=fundamental","pubTime":"2026-02-09 15:16","pubTimestamp":1770621401,"startTime":"0","endTime":"0","summary":"With the Spring Festival holiday in February, increased travel, gatherings, domestic tourism, and outbound travel are expected. The Chinese Center for Disease Control and Prevention reminds the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARDS"],"gpt_icon":0},{"id":"2608825734","title":"Healios Launches Japan Arm of Global Phase 3 Trial for ARDS Stem Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2608825734","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608825734?lang=en_us&edition=fundamental","pubTime":"2026-02-03 16:23","pubTimestamp":1770106982,"startTime":"0","endTime":"0","summary":"An update from Healios KK ( ($JP:4593) ) is now available. Healios K.K. has begun preparations to initiate patient enrollment in Japan for the glob...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healios-launches-japan-arm-of-global-phase-3-trial-for-ards-stem-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healios-launches-japan-arm-of-global-phase-3-trial-for-ards-stem-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARDS","BK4139"],"gpt_icon":0},{"id":"2604162860","title":"Healios Files Japan Trial Plan for Global Phase 3 ARDS Stem Cell Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2604162860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604162860?lang=en_us&edition=fundamental","pubTime":"2026-01-20 14:57","pubTimestamp":1768892252,"startTime":"0","endTime":"0","summary":"Healios KK ( ($JP:4593) ) has shared an announcement. Healios K.K. has submitted a clinical trial plan notification to Japan’s Pharmaceuticals and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healios-files-japan-trial-plan-for-global-phase-3-ards-stem-cell-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healios-files-japan-trial-plan-for-global-phase-3-ards-stem-cell-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ARDS"],"gpt_icon":0},{"id":"2602734391","title":"InflaRx Plans Workforce Reduction, Targets Mid-2027 Cash Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2602734391","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602734391?lang=en_us&edition=fundamental","pubTime":"2026-01-09 01:22","pubTimestamp":1767892920,"startTime":"0","endTime":"0","summary":"InflaRx outlines restructuring plans, workforce cuts, and reduced Gohibic spending to extend cash runway and focus development efforts on izicopan through mid-2027.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/08/biotech-lab.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/08/biotech-lab.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/01/49791962/inflarx-plans-workforce-reduction-targets-mid-2027-cash-runway","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/01/49791962/inflarx-plans-workforce-reduction-targets-mid-2027-cash-runway","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ARDS","IFRX","BK4139"],"gpt_icon":0},{"id":"2600702479","title":"XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2600702479","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600702479?lang=en_us&edition=fundamental","pubTime":"2026-01-01 07:15","pubTimestamp":1767222900,"startTime":"0","endTime":"0","summary":"Clinical Data doubles known genetic factors associated with urate and GoutCALGARY, Alberta, Dec.  31, 2025  (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (\"XORTX\" or the “Company”) (NASDAQ: XRTX | TSXV:","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/31/3211946/0/en/XORTX-Announces-Pioneering-Research-on-Genome-Wide-Pathogenic-Pathways-in-Gout-and-Provides-a-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XRTX","BK4139","CORD","ARDS","BK4007"],"gpt_icon":0},{"id":"2592651970","title":"MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592651970","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592651970?lang=en_us&edition=fundamental","pubTime":"2025-12-18 19:00","pubTimestamp":1766055600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Dec.  18, 2025  (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/18/3207535/7767/en/MediciNova-Announces-Completion-of-Patient-Enrollment-Evaluating-MN-166-ibudilast-in-the-Prevention-of-Chemotherapy-induced-Peripheral-Neuropathy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU2357305700.SGD","BK4534","LU1244550577.SGD","LU0971096721.USD","BK4516","BK4504","BK4139","LU0267386448.USD","IE00BZ1G4Q59.USD","LU0528227936.USD","LU1244550221.USD","LU1791710400.SGD","LU2089284900.SGD","LU2133065610.SGD","BK4127","LU1732800096.USD","LU1720051108.HKD","LU2023251221.USD","LU0158827781.USD","LU0158827948.USD","LU1363072403.SGD","IE00BKVL7J92.USD","BK4585","LU0106261372.USD","LU0795875169.SGD","BK4588","LU0098860793.USD","LU0106831901.USD","LU1989772923.USD","MNOV","LU0795875086.SGD","LU1548497426.USD","LU0234570918.USD","LU0314104364.USD","LU1074936037.SGD","ARDS","LU0557290698.USD","LU1732799900.SGD","LU1989772840.SGD","LU0882574139.USD","LU1244550494.USD","LU0225283273.USD","LU2089283258.USD","LU0320765646.SGD","LU2111349929.HKD","LU2271345857.HKD","LU1720051017.SGD","LU1791710582.SGD","LU1668664300.SGD"],"gpt_icon":0},{"id":"2590312566","title":"Healios Prioritizes ARDS Clinical Trials Over Stroke Lead Drug HLCM051","url":"https://stock-news.laohu8.com/highlight/detail?id=2590312566","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590312566?lang=en_us&edition=fundamental","pubTime":"2025-12-09 18:00","pubTimestamp":1765274449,"startTime":"0","endTime":"0","summary":"Healios will submit a clinical trial application for a global Phase 3 Acute Respiratory Distress Syndrome  study in early 2026, according to its Tokyo bourse filing on Tuesday.The group said this after shifting its development strategy for the regenerative medicine HLCM051 , now prioritizing its advancement as a treatment for ARDS in the near term.Concurrently, Healios has decided not to pursue a rolling submission for conditional approval of HLCM051 for ischemic stroke by the end of 2025 or early 2026, citing ongoing regulatory discussions and the need to allocate resources effectively.The company will continue its dialogue with regulators to reevaluate the stroke program's development path at a later date.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARDS","BK4139"],"gpt_icon":0},{"id":"2589342853","title":"MediciNova Announces Update and Basic Characteristic Randomized Patients’ of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND","url":"https://stock-news.laohu8.com/highlight/detail?id=2589342853","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589342853?lang=en_us&edition=fundamental","pubTime":"2025-12-08 19:00","pubTimestamp":1765191600,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Dec.  08, 2025  (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company listed on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchang","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201345/7767/en/MediciNova-Announces-Update-and-Basic-Characteristic-Randomized-Patients-of-Phase-2-3-Clinical-Trial-of-MN-166-Ibudilast-in-ALS-COMBAT-ALS-Clinical-Trial-Presented-at-the-36th-Inte.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU0006306889.USD","LU1244550221.USD","LU2028103732.USD","LU0234570918.USD","LU1720051108.HKD","LU0225283273.USD","LU1074936037.SGD","LU0882574139.USD","MNOV","LU0557290698.USD","LU0158827948.USD","LU1732800096.USD","LU1989772923.USD","LU0971096721.USD","LU1162221912.USD","LU1791710400.SGD","LU0795875086.SGD","LU2347655156.SGD","LU1720051017.SGD","LU1363072403.SGD","LU1732799900.SGD","LU0795875169.SGD","LU2133065610.SGD","LU2271345857.HKD","BK4588","LU0314104364.USD","BK4581","LU0106831901.USD","LU0158827781.USD","BK4127","LU0098860793.USD","LU0912757837.SGD","LU2023251221.USD","LU2111349929.HKD","BK4534","ARDS","LU0528227936.USD","LU0267386448.USD","LU0106261372.USD","LU2357305700.SGD","LU1548497426.USD","BK4585","IE00BZ1G4Q59.USD","BK4516","IE00BKVL7J92.USD","LU0320765646.SGD","LU1791710582.SGD","LU2089284900.SGD","LU1989772840.SGD"],"gpt_icon":0},{"id":"2578860854","title":"Edesa Biotech and InflaRx: Breathing New Life into ARDS Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578860854","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578860854?lang=en_us&edition=fundamental","pubTime":"2025-10-28 07:50","pubTimestamp":1761609007,"startTime":"0","endTime":"0","summary":"Edesa Biotech (($EDSA)), Inflarx N.V. (($IFRX)) announced an update on their ongoing clinical study. Study Overview: The JUST BREATHE study, offici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/edesa-biotech-and-inflarx-breathing-new-life-into-ards-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/edesa-biotech-and-inflarx-breathing-new-life-into-ards-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARDS","EDSA","BK4139"],"gpt_icon":0},{"id":"2570090978","title":"Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody","url":"https://stock-news.laohu8.com/highlight/detail?id=2570090978","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570090978?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:30","pubTimestamp":1758803400,"startTime":"0","endTime":"0","summary":"BOSTON, Sept.  25, 2025  (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), today announces it will advance its second asset, a fully human anti-IL-6 receptor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/25/3156282/0/en/Tiziana-to-Advance-TZLS-501-Its-Fully-Human-IL-6R-Monoclonal-Antibody.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0950375773.USD","LU0823417653.USD","LU2506952097.USD","BK4588","BK4533","LU2506952170.USD","LU2506951875.HKD","LU2506951958.HKD","RA","BK4085","LU1430594728.SGD","BK4139","EA","BK4585","BK4532","ARDS","BK4577","LU2247934214.USD","LU0823417737.USD","LU0006061336.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2568653471","title":"Press Release: MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2568653471","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568653471?lang=en_us&edition=fundamental","pubTime":"2025-09-18 19:30","pubTimestamp":1758195000,"startTime":"0","endTime":"0","summary":"-- Imminent launch of grant-funded clinical trial in graft-versus-host. -- Advancing clinical program in severe pulmonary inflammatory disease. \"Terese's leadership and clinical observations has advanced MiNK's INKT platform to the forefront of innovation in pulmonary diseases,\" said Jennifer S. Buell, PhD, President and Chief Executive Officer of MiNK Therapeutics. \"Her clinical work has demonstrated meaningful survival benefit and reduced infectious complications in severe acute lung injury and life-threatening hypoxemic pneumonia-- seminal findings that not only validate the potential of iNKT therapies but also set the foundation for pivotal trials and future registration.\". Dr. Terese Hammond is a nationally recognized expert in pulmonary and critical care medicine with more than two decades of leadership at top cancer and academic centers. She currently serves as Program Director of Pulmonary & Critical Care at Kaweah Health Medical Center and previously directed intensive care","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAQC","INKT","BK4139","ARDS"],"gpt_icon":0},{"id":"2567110244","title":"MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND","url":"https://stock-news.laohu8.com/highlight/detail?id=2567110244","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567110244?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:00","pubTimestamp":1758024000,"startTime":"0","endTime":"0","summary":"LA JOLLA, Calif., Sept.  16, 2025  (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/16/3150738/7767/en/MediciNova-Announces-Poster-Presentation-of-COMBAT-ALS-Clinical-Trial-at-the-36th-International-Symposium-on-ALS-MND.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU2357305700.SGD","LU0006306889.USD","BK4534","LU1244550577.SGD","LU0971096721.USD","BK4516","BK4504","LU0267386448.USD","IE00BZ1G4Q59.USD","LU1244550221.USD","LU2133065610.SGD","LU2089284900.SGD","BK4127","LU1732800096.USD","LU1720051108.HKD","LU2023251221.USD","LU0158827781.USD","LU2028103732.USD","LU0158827948.USD","LU1363072403.SGD","IE00BKVL7J92.USD","BK4585","LU0106261372.USD","LU0795875169.SGD","LU1668664300.SGD","BK4588","LU0098860793.USD","LU0106831901.USD","LU1989772923.USD","MNOV","LU0795875086.SGD","LU1548497426.USD","LU0234570918.USD","LU0314104364.USD","LU1074936037.SGD","ARDS","LU1732799900.SGD","LU1989772840.SGD","LU0882574139.USD","LU1244550494.USD","LU2347655156.SGD","LU0225283273.USD","LU2089283258.USD","LU0320765646.SGD","LU2111349929.HKD","LU2271345857.HKD","LU1720051017.SGD","BK4581","LU1162221912.USD"],"gpt_icon":0},{"id":"1129472747","title":"The Concentration of Ten-Fold Bull Stocks in This Bull Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1129472747","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129472747?lang=en_us&edition=fundamental","pubTime":"2025-08-23 14:10","pubTimestamp":1755929452,"startTime":"0","endTime":"0","summary":"In this bull market rally, indices have continuously reached new highs. This Friday, the Shanghai Composite Index successfully broke through 3,800 points, reaching a peak of 3,825.76 points. Among...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARDS"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}